Validation of a fast and simple peripheral blood diagnostic biomarker kit for Alzheimer’s disease

Project Information

ADDIA

Grant agreement ID: 674474

DOI

10.3030/674474

Project closed

EC signature date 10 July 2015

Start date 1 August 2015

End date 31 July 2019

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 4 998 625,00

EU contribution

€ 4 998 625,00

Coordinated by

AMONETA DIAGNOSTICS
France

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (2)

Letters and project updates to patient organisation Alzheimer Europe

AD patient organizations will be contacted to disseminate the project progress regarding AD diagnosis with the ADDIA assay to AD patients and their families, via announcements on patient organization’s websites and sending out letters.

Scientific papers prepared for peer-reviewed open access journals

Amoneta aims to raise the awareness, acceptance and support of the scientific and medical experts regarding the novel IVD assay for AD diagnosis:  Outcomes from the ADDIA project will be presented at international and national conferences.  Regular updates (in the form of abstracts, presentations, posters) regarding the progress of the project and the preliminary results will be provided to all relevant scientific organisations at European and international level.  Scientific articles of the findings of the clinical trial will be published in (open access) peer reviewed scientific and medical journals.

Publications

Conference proceedings (2)

ADDIA Chronobiology Study and Proof-of-Performance Study to Validate Blood-Based Biomarkers for the Diagnostic of early Alzheimer’s Disease (AD)

Author(s): F. Blanc, F. Giovanni, M. Marizzoni, C. Mutter, J.C. Bier, F. Sellal, J.F. Démonet, S. Boutillier, H. Firat, S. Moussaoui, R. David, A. Ivanoiu, E. Magnin, A. Gabelle, F. Pasquier, H. Gurvit, B. Dubois
Published in: 2019
Publisher: Alzheimer's and Parkinson's diseases

Addia, a Multi- Center Clinical Study of Proof-of-Performance to Validate Blood-Based Biomarkers for the Diagnostic of Alzheimer’s Disease (AD): The Study Protocol.

Author(s): Bruno Dubois, MD, PhD, Professor, Jean-Christophe Bier, MD, Frederic Blanc, MD, PhD, Renaud David, MD, PhD, Jean-François Démonet, MD, PhD, Hüseyin Firat, MD, PhD, Giovanni B Frisoni, Prof, PhD, MD, Audrey Gabelle, MD, PhD, Hakan I. Gurvit, MD, Adrian Ivanoiu, MD, PhD, Eloi Magnin, MD, PhD, Moira Marizzoni, PhD, Saliha Moussaoui, PhD, Florence Pasquier, MD PhD and François Sellal, MD
Published in: 2018
Publisher: Alzheimer's Association International Conference

Intellectual Property Rights

Patent (7)

NON-CODING RNAS (NCRNA) FOR THE DIAGNOSIS OF COGNITIVE DISORDERS

Application/Publication number: WO 2019048500
Date: 2017-09-05
Applicant(s): AMONETA DIAGNOSTICS

DETECTION OF NEURODEGENERATIVE DISEASES

Application/Publication number: EP 17719325
Date: 2017-03-07
Applicant(s): AMONETA DIAGNOSTICS

DIPYRROMETHENE-BORON HYDROPHILIC FLUORESCENT COMPOUNDS

Application/Publication number: EP 09805741
Date: 2009-12-18
Applicant(s): AMONETA DIAGNOSTICS

Unsaturated dibenzopyrromethene-boron borocarbons

Application/Publication number: WO2006/087458 2006/087458
Date: 2005-02-15
Applicant(s): AMONETA DIAGNOSTICS

NOVEL FLUORESCENT BORON-SUBSTITUTED DIPYRROMETHENES AND USE THEREOF FOR DIAGNOSIS

Application/Publication number: EP 09806180
Date: 2009-12-28
Applicant(s): AMONETA DIAGNOSTICS

UNSATURATED DIPYRROMETHENE-BORON BOROCARBONS

Application/Publication number: EP 06709313
Date: 2006-02-14
Applicant(s): AMONETA DIAGNOSTICS

Biological complex specific for Alzheimer's disease detection in vitro and use thereof

Application/Publication number: US20130289140 20130289140
Date: 2013-04-30
Applicant(s): AMONETA DIAGNOSTICS